Tech-centric performance training company Exos has acquired Infinite Athlete and its subsidiary, Biocore, to bolster its ...

Orion Oyj (ORINY) reports robust growth in operating profit and innovative medicines, despite facing delivery delays and increased fixed costs.

An announcement from Evaxion Biotech ( ($EVAX) ) is now available. On October 30, 2025, Evaxion A/S announced it raised $7.2 million, extending ...

Rocky Brands, Inc. delivered strong Q3 '25 results, with broad-based revenue growth and significant gross margin expansion.

CEMEX, S.A.B. de C.V. posts record 3Q25 margins from strong pricing, but volume concerns and high valuation raise caution.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, has selected Shiftconnector® to improve how it uses digital tools in manufacturing. By integrating Shiftconnector® into its ...

US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has ...

A multinational analysis and Swedish registry data show higher dementia mortality after age 80 and a twofold dementia risk in ...

UBS upgrades Victoria’s Secret to ‘buy,’ raising its price target to $46 and forecasting a strong turnaround and 33% upside ...

Training and wellness company Exos, having acquired Infinite Athlete and its subsidiary, Biocore, is betting that the tech and expertise used by the NFL to improve player performance can scale to ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.

Merck & Co, known as MSD outside of the USA and Canada, and Japan’s Eisai today announced that the Phase III LITESPARK-011 ...